Login / Signup
Morgan Neve
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Chemotherapy Induced
Epidermal Growth Factor Receptor
Low Dose
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Rhonda L Bitting
,
Janet A Tooze
,
Michael Goodman
,
Donald C Vile
,
Jessica M Brown
,
Christopher Y Thomas
,
Morgan Neve
,
Mitra Kooshki
,
Safoa Addo
,
Pierre L Triozzi
,
Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Cancer research communications
4 (2) (2024)
Rhonda L Bitting
,
Janet A Tooze
,
Michael Goodman
,
Donald C Vile
,
Jessica M Brown
,
Christopher Y Thomas
,
Morgan Neve
,
Mitra Kooshki
,
Safoa Addo
,
Pierre L Triozzi
,
Purnima Dubey
Low Dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum Refractory Urothelial Carcinoma.
Cancer research communications
(2024)
Rhonda L Bitting
,
Janet A Tooze
,
Michael Goodman
,
Donald C Vile
,
Jessica M Brown
,
Christopher Y Thomas
,
Morgan Neve
,
Mitra Kooshki
,
Safoa Addo
,
Pierre L Triozzi
,
Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Cancer research communications
4 (2) (2024)